Paul Tudor Jones Dexcom Inc Put Options Transaction History

Tudor Investment Corp Et Al

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $2.5 Million - $3.19 Million	22,700 New	22,700 $2.57 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $868,134 - $1.43 Million	-11,500 Reduced 76.67%	3,500 $434,000
Q3 2023 Nov 15, 2023	BUY	$86.06 - $137.93 $438,906 - $703,443	5,100 Added 51.52%	15,000 $1.4 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $854,772 - $995,447	7,600 Added 330.43%	9,900 $1.27 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $509,600 - $602,308	-4,900 Reduced 68.06%	2,300 $268,000
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $611,856 - $883,224	7,200 New	7,200 $814,000
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $353,548 - $691,027	5,200 New	5,200 $388,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.